Vesicular monoamine transporters: structure-function, pharmacology, and medicinal chemistry.

Medicinal Research Reviews
Kandatege Wimalasena

Abstract

Vesicular monoamine transporters (VMAT) are responsible for the uptake of cytosolic monoamines into synaptic vesicles in monoaminergic neurons. Two closely related VMATs with distinct pharmacological properties and tissue distributions have been characterized. VMAT1 is preferentially expressed in neuroendocrine cells and VMAT2 is primarily expressed in the CNS. The neurotoxicity and addictive properties of various psychostimulants have been attributed, at least partly, to their interference with VMAT2 functions. The quantitative assessment of the VMAT2 density by PET scanning has been clinically useful for early diagnosis and monitoring of the progression of Parkinson's and Alzheimer's diseases and drug addiction. The classical VMAT2 inhibitor, tetrabenazine, has long been used for the treatment of chorea associated with Huntington's disease in the United Kingdom, Canada, and Australia, and recently approved in the United States. The VMAT2 imaging may also be useful for exploiting the onset of diabetes mellitus, as VMAT2 is also expressed in the β-cells of the pancreas. VMAT1 gene SLC18A1 is a locus with strong evidence of linkage with schizophrenia and, thus, the polymorphic forms of the VMAT1 gene may confer susceptibility to...Continue Reading

References

Nov 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·J D EricksonB J Hoffman
Jan 1, 1986·Biochimica Et Biophysica Acta·D NjusG J Harnadek
Apr 1, 1988·Journal of Neurochemistry·D SchermanY Agid
May 17, 1969·British Medical Journal·M A Dalby
Sep 28, 1984·Science·J W LangstonL S Forno
Jan 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·D SchermanJ P Henry
Apr 1, 1995·Physiological Reviews·S SchuldinerM Linial
Dec 1, 1993·Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine·J N DaSilvaT J Mangner
Jun 1, 1994·Journal of Neurochemistry·S Schuldiner
Apr 11, 1994·FEBS Letters·B GasnierJ P Henry
Apr 15, 1994·Biochemical and Biophysical Research Communications·K WimalasenaD S Wimalasena
Dec 1, 1993·Journal of Neurochemistry·J D Erickson, L E Eiden
Feb 5, 1993·Journal of Molecular Biology·C Landolt-MarticorenaR A Reithmeier
May 14, 1996·Proceedings of the National Academy of Sciences of the United States of America·J D EricksonE Weihe

❮ Previous
Next ❯

Citations

Sep 29, 2011·Amino Acids·Anne SaulinRupert Lanzenberger
Sep 7, 2012·Diabetes, Obesity & Metabolism·P E Harris, R L Leibel
May 10, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Aleksandra H Nall, Amita Sehgal
Nov 20, 2013·Neurochemical Research·Yutaka TamuraTetsufumi Ueda
Oct 29, 2013·Translational Research : the Journal of Laboratory and Clinical Medicine·Feng HongJin-Xia Zhu
Aug 19, 2015·Phytotherapy Research : PTR·Jae-Sun ChoiJoo-Won Jeong
Sep 3, 2011·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·A DlugoszG Lindberg
Dec 3, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Eugene V MosharovDavid Sulzer
Oct 2, 2012·Brain Research Bulletin·James M MaySergey Dikalov
Oct 29, 2013·Pharmacology, Biochemistry, and Behavior·Olivia F O'LearyJohn F Cryan
Apr 12, 2013·Ultrastructural Pathology·Ismini Kloukina-PantazidouMarietta R Issidorides
Jul 9, 2016·Progress in Neurobiology·Philippe De DeurwaerdèreMark J Millan
Aug 9, 2016·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Bojana StefanovicSladjana Dronjak
Aug 16, 2016·The European Journal of Neuroscience·Kelly M LohrGary W Miller
Nov 1, 2016·Journal of Immunology Research·Rodrigo ArreolaLenin Pavón
Nov 12, 2016·Journal of Chemical Neuroanatomy·Rachel A CliburnGary W Miller
Mar 12, 2015·Reviews in Medical Virology·Shahzma MeraniShokrollah Elahi
Aug 18, 2017·Molecular Biology of the Cell·Bhavani S SahuMargaret S Robinson
Oct 11, 2016·World Journal of Radiology·Junfeng LiFouad Kandeel
Jun 8, 2018·European Journal of Endocrinology·Annika M A BerendsAnouk N A van der Horst-Schrivers
Dec 21, 2018·Arteriosclerosis, Thrombosis, and Vascular Biology·Maleeha F AhmadStephanie W Watts
Sep 8, 2017·CNS Spectrums·Martin StrassnigPhilip D Harvey
Feb 7, 2019·Neurodegenerative Disease Management·Natalie Witek, Cynthia Comella
Apr 14, 2017·The Journal of Pharmacology and Experimental Therapeutics·Dimitri E GrigoriadisHaig Bozigian
Nov 7, 2019·Journal of Clinical Psychopharmacology·Jacob SchultzRif S El-Mallakh
Oct 16, 2019·Expert Opinion on Pharmacotherapy·Daniel O ClaassenBenjamin Carroll
Mar 8, 2017·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Thamara E OsingaIdo P Kema
Dec 27, 2016·Frontiers in Neuroscience·Haruo Nishijima, Masahiko Tomiyama
Jul 19, 2019·Endocrine Pathology·Kleopatra GeorgantziLars Grimelius
Jun 18, 2020·Frontiers in Pharmacology·Silvia ReaDavide Lauro
Dec 10, 2016·Frontiers in Neuroscience·Giuseppe Di GiovanniPhilippe De Deurwaerdère
Nov 29, 2013·Journal of Labelled Compounds & Radiopharmaceuticals·Michael R Kilbourn
Aug 26, 2020·Nature Reviews. Endocrinology·Guido Rindi, Bertram Wiedenmann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Early Markers

Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive cognitive and behavioral decline. Targeting markers in the earliest stages of the disease may mitigate the progression of AD. This feed focuses on early diagnosis and markers, as well as environmental, pharmacological, and drug-response biomarkers associated with this disease.

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.